Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.

Abstract

Lung impairment is the most life-threatening factor for cystic fibrosis patients. Indeed, Pseudomonas aeruginosa is the main pathogen in the pulmonary infection of these patients. In this work, we developed sodium colistimethate loaded lipid nanoparticles, namely, solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), as a strategy to… (More)
DOI: 10.1016/j.ijpharm.2014.10.048

Topics

6 Figures and Tables

Cite this paper

@article{Pastor2014SodiumCL, title={Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.}, author={M. Carmen Pastor and Mar{\'i}a Moreno-Sastre and Amaia Esquisabel and Eul{\`a}lia Sans and Miguel Vi{\~n}as and Daniel Bachiller and V{\'i}ctor Jos{\'e} Asensio and Angel del Pozo and Eusebio Gainza and Jos{\'e} Lu{\'i}s Pedraz}, journal={International journal of pharmaceutics}, year={2014}, volume={477 1-2}, pages={485-94} }